[
    [
        {
            "time": "2021-Q2",
            "original_text": "细 胞 基 因 治 疗 2 0 2 1 Q 2 跟 踪 ： 行 业 风 口 正 盛 看 好 产 业 链 上 游 及 C D M O 企 业 发 展",
            "features": {
                "keywords": [
                    "细胞基因治疗",
                    "行业风口",
                    "产业链上游",
                    "CDMO企业"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "CDMO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "细 胞 基 因 治 疗 2 0 2 1 Q 2 跟 踪 ： 行 业 风 口 正 盛 看 好 产 业 链 上 游 及 C D M O 企 业 发 展",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-08-25",
            "original_text": "康 龙 化 成 ( 3 0 0 7 5 9 ) 2 0 2 1 年 中 报 点 评 ： 2 1 H 1 业 绩 符 合 预 期 一 站 式 协 同 效 应 初 见 成 效",
            "features": {
                "keywords": [
                    "康龙化成",
                    "中报点评",
                    "业绩符合预期",
                    "一站式协同效应"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药研发服务"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康 龙 化 成 ( 3 0 0 7 5 9 ) 2 0 2 1 年 中 报 点 评 ： 2 1 H 1 业 绩 符 合 预 期 一 站 式 协 同 效 应 初 见 成 效",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-H1",
            "original_text": "康 龙 化 成 2 0 2 1 年 上 半 年 实 现 净 利 润 5 . 4 7 亿 元 ， 同 比 增 长 1 7 . 2 8 %",
            "features": {
                "keywords": [
                    "康龙化成",
                    "净利润",
                    "同比增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药研发服务"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康 龙 化 成 2 0 2 1 年 上 半 年 实 现 净 利 润 5 . 4 7 亿 元 ， 同 比 增 长 1 7 . 2 8 %",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 3,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-08-25",
            "original_text": "【 异 动 股 】 康 龙 化 成 ( 0 3 7 5 9 . H K ) 涨 4 . 2 2 %",
            "features": {
                "keywords": [
                    "康龙化成",
                    "异动股",
                    "股价上涨"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药研发服务"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【 异 动 股 】 康 龙 化 成 ( 0 3 7 5 9 . H K ) 涨 4 . 2 2 %",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 9,
                "Duration": 2,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-H1",
            "original_text": "康 龙 化 成 ( 0 3 7 5 9 . H K ) 中 期 股 东 溢 利 增 长 1 7 . 9 % 至 人 民 币 5 . 6 5 亿 元",
            "features": {
                "keywords": [
                    "康龙化成",
                    "股东溢利增长",
                    "中期业绩"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药研发服务"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康 龙 化 成 ( 0 3 7 5 9 . H K ) 中 期 股 东 溢 利 增 长 1 7 . 9 % 至 人 民 币 5 . 6 5 亿 元",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 3,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]